SSX2 knockdown, in the 22Rv1 prostate cancer line, demonstrated a large fold change in many different EMT associated genes (TWIST1, ZEB2, MMP2, VIM, CDH1, CDH2) however these genes did not respond in an anticipated or canonical way (Figure 2E). This evidence concerns the gene VIM and prostate carcinoma.